Starting low reduces the risk of gastrointestinal side effects that can occur when the body first encounters GLP-1 and GIP receptor stimulation
Studies examining the efficacy of GLP-1 drugs used for weight loss have generally quantified changes in fat and lean mass, with changes in lean mass serving as a surrogate for muscle mass
Hussaarts, K.G., Hurkmans, D.P., Oomen-de Hoop, E., van Harten, L.J., Berghuis, S., van Alphen, R.J., Spierings, L.E., van Rossum-Schornagel, Q.C., Vastbinder, M.B., van Schaik, R.H
Both injectable and oral options are available
Ma questo ha senso
We provide both brand-name semaglutide (Ozempic, Wegovy) and compounded formulations including compounded semaglutide with L-Carnitine for patients who want added metabolic support or who may not be the best fit for brand-name options